Contents

CNS & Neurological Disorders - Drug Targets , Volume 11 - Number 3

Conference Report

, 11(3): 191

Stephen D. Skaper


DOI: 10.2174/187152712800672427




Commentary

, 11(3): 192

Stephen D. Skaper


DOI: 10.2174/187152712800672391




Editorial [Hot Topic: COMT as a Drug Target for Nervous System Disorders (Guest Editor: Francesco Papaleo)]

, 11(3): 193 - 194

Francesco Papaleo


DOI: 10.2174/187152712800672508




Catechol-O-Methyl Transferase Modulates Cognition in Late Life: Evidence and Implications for Cognitive Enhancement

, 11(3): 195 - 208

Fabio Sambataro, Maria Pennuto and Robert Christian Wolf


DOI: 10.2174/187152712800672463




COMT as a Drug Target for Cognitive Functions and Dysfunctions

, 11(3): 209 - 221

Diego Scheggia, Sara Sannino, Maria Luisa Scattoni and Francesco Papaleo


DOI: 10.2174/187152712800672481




Janus Molecule I: Dichotomous Effects of COMT in Neuropathic vs Nociceptive Pain Modalities

, 11(3): 222 - 235

S. K. Segall, W. Maixner, I. Belfer, T. Wiltshire, Z. Seltzer and L. Diatchenko


DOI: 10.2174/187152712800672490




The Role of the Catechol-O-Methyltransferase (COMT) Gene in Personality and Related Psychopathological Disorders

, 11(3): 236 - 250

Christian Montag, Magdalena Jurkiewicz and Martin Reuter


DOI: 10.2174/187152712800672382




Role of Catechol-O-Methyltransferase (COMT)-Dependent Processes in Parkinson’s Disease and L-DOPA Treatment

, 11(3): 251 - 263

Stefano Espinoza, Francesca Manago, Damiana Leo, Tatyana D. Sotnikova and Raul R. Gainetdinov


DOI: 10.2174/187152712800672436




Catechol-O-Methyltransferase (COMT) Pharmacogenetics in the Treatment Response Phenotypes of Major Depressive Disorder (MDD)

, 11(3): 264 - 272

Neslihan Aygun Kocabas


DOI: 10.2174/187152712800672445




COMT Implication in Cognitive and Psychiatric Symptoms in Chromosome 22q11 Microdeletion Syndrome: A Selective Review

, 11(3): 273 - 281

Marco Armando, Francesco Papaleo and Stefano Vicari


DOI: 10.2174/187152712800672526




Catechol-O-Methyl Transferase as a Drug Target for Schizophrenia

, 11(3): 282 - 291

Colm M.P. O’Tuathaigh, Lieve Desbonnet, Peter Lee and John L. Waddington


DOI: 10.2174/187152712800672418




Current Understanding of the Interplay Between Catechol-OMethyltransferase Genetic Variants, Sleep, Brain Development and Cognitive Performance in Schizophrenia

, 11(3): 292 - 298

Valter Tucci, Glenda Lassi and Martien J. Kas


DOI: 10.2174/187152712800672454




Catechol-O-Methyltransferase and Alzheimer's Disease: A Review of Biological and Genetic Findings

, 11(3): 299 - 305

Alessandro Serretti and Paolo Olgiati


DOI: 10.2174/187152712800672472




The Role of Catechol-O-Methyltransferase in Reward Processing and Addiction

, 11(3): 306 - 323

E. M. Tunbridge, A. Huber, S. M. Farrell, K. Stumpenhorst, P. J. Harrison and M. E. Walton


DOI: 10.2174/187152712800672409




Inhibitors of Catechol-O-Methyltransferase

, 11(3): 324 - 332

James C. Barrow


DOI: 10.2174/187152712800672517




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science